Download Symposia - WCP2018

Symposia
No.
*Symposia titles are tentative.
As of April 10, 2017
Title (tentative)
Role
Organizer(s)
Affiliation
Country
1
Drug design based on 3D microstructure of receptors
Organizer
Yuji Ikegaya
The University of Tokyo
Japan
2
Alzheimer's disease: ultra-early stage diagnosis and
treatment
Organizer
Takeshi Iwatsubo
Department of Neuropathology, Graduate
School of Medicine, The University of Tokyo
Japan
3
Shortened life span in patients with schizophrenia: Life
style related problems and clinical pharmacology of
antipsychotics
Organizer
Kazutaka Shimoda
Department of Psychiatry, Dokkyo Medical
University
Japan
4
Novel approaches towards understanding psychiatric
disorders: inflammation in the brain and periphery
Organizer
Tomoyuki Furuyashiki
Division of Pharmacology, Kobe University
Graduate School of Medicine
Japan
5
Brain-Gut Axis
Organizer
Ludmila Filaretova
Pavlov Institute of Physiology
Russia
6
Transformative technologies at the forefront of brain
research
Organizer
Haruhiko Bito
Department of Neurochemistry, Graduate
School of Medicine, The University of Tokyo
Japan
Haruhiko Bito
Department of Neurochemistry, Graduate
School of Medicine, The University of Tokyo
Japan
Grey Stephens
University of Reading
UK
7
Ca2+ signaling in health and disease
Organizers
8
Novel regulations and functions of dopaminergic systems
towards understanding psychiatric disorders
Organizer
Tomoyuki Furuyashiki
Division of Pharmacology, Kobe University
Graduate School of Medicine
Japan
9
Alpha-synuclein in Parkinson's disease
Organizer
Masahiro Nomoto
Ehime University
Japan
10
Recent advances in the development of subtype-selective
and signaling-biased drugs for D2-like dopamine receptors:
Organizer
towards improved therapeutics for neuropsychiatric
disorders
David R. Sibley
Molecular Neuropharmacology Section
National Institute of Neurological Disorders &
Stroke/NIH
USA
11
Emerging therapeutic targets against autism spectrum
disorder
Organizer
Chan Young Shin
Department of Pharmacology, School of
Medicine, Konkuk University
Korea
12
Mechanisms of maladaptive plasticity in animal models of
neuropsychiatric disorders
Organizer
Maurizio Popoli
Department of Pharmacological and
Biomolecular Sciences - University of Milano
Italy
Clare Stanford
UCL IRIS
UK
Mark Tricklebank
Centre for Neuroimaging Sciences, Institute of
Psychiatry and Psychology and Neuroscience, UK
King’s College London
13
The function and pharmacology of the neuronal reninangiotensin system
Organizers
14
ADHD and Substance Use Disorders: epidemiology,
neurobiology and treatment
Organizer
Wim van den Brink
Department of Psychiatry, Academic Medical
Center University of Amsterdam
The Netherlands
15
Pain Sensor
Organizer
Yasuo Mori
Graduate School of Engineering, Kyoto
University
Japan
16
Central Pain and Translation
Organizer
Fusao Kato
Department of Neuroscience, Jikei University
School of Medicine
Japan
17
Basic and clinical pharmacology of anti-arteriosclerotic
effect of anti-inflammatory drugs
Hiroshi Watanabe
Department of Clinical Pharmacology and
Therapeutics, Hamamatsu University School of Japan
Medicine
Organizer
18
Therapeutic strategy to enhance intrinsic resistance in
cardiovascular system
Organizer
Motohiro Nishida
Division of Cardiocirculatory Signaling
Okazaki Institute for Integrative Bioscience
Japan
(National Institute for Physiological Sciences),
National Institutes of Natural Sciences
19
New therapeutic approach for cardiorenal syndromeintegration of basic and clinical Pharmacological evidence
Organizer
Akira Nishiyama
Department of Pharmacology, Kagawa
University Medical School
20
Recent advances in the molecular and cellular
understanding of heart failure
--Toward novel therapeutic strategies
Yasushi Fujio
Laboratory of Clinical Science and Biomedicine
Graduate School of Pharmaceutical Sciences, Japan
Osaka University
Organizer
1
Japan
Symposia
No.
21
22
23
*Symposia titles are tentative.
Title (tentative)
Hypertension: New developments in understanding and
management
Cutting edge of calcium permeable ion channels in
diseases as potential targets of drug discovery
Endothelial Mechanosensing in Vascular Physiology and
Disease
As of April 10, 2017
Role
Organizer(s)
Affiliation
Country
David Webb
University of Edinburgh
UK
Bean Dhaun
University of Edinburgh
UK
Yuji Imaizumi
Graduate School of Pharmaceutical Sciences,
Nagoya City University
Japan
David J. Beech
University of Leeds
UK
Naoki Mochizuki
National Cerebral and Cardiovascular Center
Research Institute
Japan
Stefan Offermanns
Max Planck Institute for Heart and Lung
Research
Germany
Organizers
Organizers
Organizers
24
Lower Urinary Tract Dysfunction Update: New Insight into
Organizer
Pharmacological Mechanisms1
Hidehiro Kakizaki
Department of Renal and Urologic Surgery,
Asahikawa Medical University
Japan
25
New pharmacological approaches for renal diseases
Akira Nishiyama
Department of Pharmacology, Kagawa
University Medical School
Japan
Yukihiko Sugimoto
Kumamoto University
Japan
Masataka Majima
Department of Pharmacology, Kitasato
University School of Medicine
Japan
Japan
26
Roles of Bioactive Lipids in Inflammatory Diseases
Organizer
Organizers
27
Advances in molecular targeting therapy for rheumatoid
arthritis
Organizer
Masayoshi Harigai
Division of Epidemiology and
Pharmacoepidemiology,
Institute of Rheumatology, Tokyo Women’s
Medical University
28
Immunology and Inflammation
Organizer
Satoshi Uematsu
Department of Mucosal Immunology, School
of Medicine, Chiba University
Japan
Department of Immunology
Graduate School of Medicine and Faculty of
Medicine, The University of Tokyo
Japan
29
Molecular targets and imaging studies in bone diseases
Organizer
Hiroshi Takayanagi
30
New Controllers of Inflammation: What are the hottest
targets?
Organizer
Francesca Levi-Schaffer The Hebrew University of Jerusalem
Israel
31
Translational Research in GI Pharmacology - Novel
therapeutic strategy in GI diseases -
Organizer
Koji Takeuchi
Japan
32
Present status and future perspective of gastric acid
inhibitor
Organizer
Takahisa Furuta
Hamamatsu University School of Medicine
Kyoto Pharmaceutical University
Japan
33
iPS cells and disease
Organizer
Haruhisa Inoue
Department of Cell Growth and Differentiation,
Center for iPS Cell Research and Application
Japan
(CiRA), Kyoto University
34
Humanized Mouse Models and iPSC as tools to study drug
toxicity
Organizer
Darrell R. Abernethy
US Food and Drug Administration/Johns
Hopkins University School of Medicine
USA
35
Innovations in Overcoming Diabetes and Complications
Organizer
Momir Mikov
Department of Pharmacology and Toxicology,
University of Novi Sad
Serbia
36
Role of mitochondria and oxidative stress in metabolic
syndrome
Organizer
Julie Y.H. Chan
Kaohsiung Chang Gung Memorial Hospital
Taiwan
37
Novel Therapeutic Strategies for Respiratory Diseases
Organizer
WS Fred Wong
The National University of Singapore, Yong
Loo Lin School of Medicine
Singapore
38
Understanding living systems by extensive analyses of all
cells
Organizer
Hiroki R. Ueda
Graduate School of Medicine, University of
Tokyo/ RIKEN QBiC
Japan
2
Symposia
No.
*Symposia titles are tentative.
As of April 10, 2017
Title (tentative)
Role
Organizer(s)
Affiliation
Country
39
Systems Biology and Drug Targeting
Organizer
Mariko Okada
Laboratory of Cell Systems, Institute for
Protein Research, Osaka University
Japan
40
Targeting antioxidant defence system in redox diseases
Organizer
Mi-Kyoung Kwak
The Catholic University of Korea, College of
Pharmacy
Korea
Ryoichiro Kageyama
Kyoto University Institute for Virus Research
Japan
41
Photobiology: understanding of biological systems by
illuminating and controlling biological functions by light
Organizers
Cyril Goudet
Institut de Génomique Fonctionnelle, France
France
42
European & Asian training initiatives to improve safe and
effective use of medicines in modern healthcare
Organizer
Shinichiro Ueda
University of the Ryukyus
Japan
43
Experiences and models for strengthening pharmacological
research, teaching and services in resource strained
Organizer
countries
Collen Masimirembwa
African Institute of Biomedical Science &
Technology (AiBST)
Zimbabwe
44
IPE: Educating a New Generation of Healthcare
Professionals to Prescribe Medications Safely and
Effectively
Kelly Dowhower Karpa
Pennsylvania State University College of
Medicine
USA
45
Introducing the IUPHAR Pharmacology Education Project Organizer
www.pharmacologyeducation.org
John L. Szarek
The Commonwealth Medical College
USA
46
Frontiers in approaching retinal research - The current
status and future in development of therapeutic strategies Organizer
based on genetic and iPS methods-
Hideaki Hara
Gifu Pharmaceutical University, Molecular
Pharmacology
Japan
47
Novel targets and biomarkers for Anticancer Therapeutics
Organizer
Atsushi Ohtsu
National Cancer Center Japan
Japan
48
Cancer Drug Resistance
Organizer
Mi-Kyoung Kwak
The Catholic University of Korea, College of
Pharmacy
Korea
Japan
Organizer
49
Therapeutic manipulation of RNA/DNA for genetic diseases Organizer
Masatoshi Hagiwara
Department of Anatomy and Developmental
Biology, Kyoto University Graduate School of
Medicine
50
Multidisciplinary Approach on Molecular Bio-imaging from
Basic to Clinical Pharmacological Studies
Organizer
Kazuhiko Yanai
Department of Pharmacology, Tohoku
University School of Medicine
Japan
51
Vaccine Drug Diagnostic Development for the control of
Emerging Infectious Diseases
Organizer
Kouichi Morita
NEKKEN, Nagasaki Univ
Japan
52
All for Global Health, Global Health for All
Organizer
Kenji Hirayama
NEKKEN、Nagasaki University
Japan
53
Optimising drug selection and dosage in treating infectious
Organizer
diseases in children and pregnant women in Africa
Lars L. Gustafsson
Division of Clinical Pharmacology, Department
Sweden
of Laboratory Medicine, Karolinska Institutet
54
New Drugs for Emerging Infectious Disease
Organizer
Mauro Teixeira
Department Biochemistry and Immunology,
Universidade Federal de Minas Gerais
Brazil
55
Globalization of Traditional Asian Medicine
Organizer
Haruki Yamada
Kitasato University
Japan
56
Ameliorating effects of traditional Chinese medicine on
ischemia/reperfusion-induced cerebral microcirculatory
disturbances and neuron damage
Organizer
Jing-Yan Han
Department of Integration of Chinese and
Western Medicine, Peking University Health
Science Center
China
57
Pharmacological investigation in new drug discovery
Organizer
Guanhua Du
Institute of Materia Medica, Chinese Academy
China
of Medical Sciences
58
Network pharmacology
Organizer
Wenxia Zhou
Beijing Institute of Pharmacology and
Toxicology
3
China
Symposia
No.
*Symposia titles are tentative.
Title (tentative)
As of April 10, 2017
Role
Organizer(s)
Affiliation
Country
Japan
59
Global clinical trials and ethnic factors
Organizer
Masahiro Tohkin
Department of Regulatory Science, Graduate
School of Pharmaceutical Sciences, Nagoya
City University
60
Role of database study in pharmacovigilance
Organizer
Kiyoshi Kubota
NPO Drug Safety Research Unit Japan
Japan
Phil Routledge
Cardiff University
UK
David Webb
University of Edinburgh
UK
Daniel Antoine
University of Liverpool and MRC Centre for
Drug Safety Science
UK
61
Health Technology Assessment (HTA) for Smaller
Countries: the central role of clinical pharmacology
Organizers
62
Novel biomarkers, predictors and models for drug-induced
Organizer
liver injury
63
Toxicogenomics for accelerated and refined hazard
identification of chemicals
Organizer
Jun Kanno
Japan Bioassay Research Center
Japan Organization of Occupational Health and Japan
Safety
64
Pharmacogenomics in drug therapy; future perspective,
next generation of pharmacogenomics
Organizer
Ichiro Ieiri
Kyushu University
Japan
65
Posttranslational modification of nuclear receptors as
therapeutic targets
Organizer
InKyeom Kim
Kyungpook National University School of
Medicine
Korea
66
Pharmacogenomics in Special Populations
Guilherme Suarez-Kurtz Brazilian Pharmacogenomics Network
Brazil
Andrew Somogyi
University of Adelaide
Australia
Organizers
67
Horizon of PMx
Organizer
Yuji Kumagaya
Kitasato University Hospital Clinical Trial
Center
Japan
68
Recent progress of immunosuppressant TDM
Organizer
Satohiro Masuda
Department of Pharmacy, Kyushu University
Hospital
Japan
69
Pharmacokinetic/-dynamic modelling
- Population PK/PD-models
- Physiology-based PK (PBPK) models
- PK/PD models: application in paediatrics
- PB/PK-modelling: regulatory aspects
Organizer
Petra A. Thürmann
University Witten/Herdecke, HELIOS Hospital
Wuppertal
Germany
70
The prediction of renal drug transport: a story with many
tales
Organizer
Rosalinde Masereeuw
Utrecht Institute for Pharmaceutical Sciences,
The Netherlands
Div. Pharmacology
71
Innovative apprach to pediatric drug development and
clinical practice
Topics include pharmacogenomics, pharmacometrics and
new formulations.
Organizer
Hidefumi Nakamura
National Center for Child Health and
Development
Japan
72
Open Innovation for Drug Discovery
Organizer
Chikako Saotome
Department of Drug Discovery Medicine,
Kyoto University Graduate School of Medicine
Japan
A. Mark Evans
University of Edinburgh
UK
73
System pharmacology of the AMPK-activated protein
kinase
Organizers
Graham Hardie
University of Dundee
UK
74
Molecular pharmacology focused studies of calcium
permeable ion channels: identifying new pharmacological
targets and therapies
Organizer
Gregory Monteith
The School of Pharmacy, The University of
Queensland
Australia
75
TBA
Organizer
National Doping Control Centre, Mahidol
Supornchai Kongpatanakul
University
Thailand
David Gloriam
University of Copenhagen
Denmark
76
Computational Pharmacology, Databases and Drug
Discovery
Adam Pawson
University of Edinburgh
UK
Organizers
4
Symposia
No.
*Symposia titles are tentative.
Title (tentative)
As of April 10, 2017
Role
77
3D microtissues in drug discovery: mechanopharmacology Organizer
78
The BPS Focus on Pharmacology Project: Securing the
future of Pharmacology & Clinical Pharmacology
79
Nutrient and Metabolite Sensing by GPCRs, or more
broadly: Novel Natural Ligands and Functions of GPCRs
Organizer(s)
Affiliation
Country
Alastair Stewart
Department of Pharmacology and
Therapeutics, University of Melbourne
Australia
David Webb
University of Edinburgh
UK
Jonathan Bruun
British Pharmacological Society
UK
Kazuwa Nakao
Medical Innovation Center, Kyoto University
Graduate School of Medicine
Japan
Stefan Offermanns
Max Planck Institute for Heart and Lung
Research
Germany
Kevin Pfleger
Harry Perkins Institute of Medical Research
Australia
Michelle Halls
Monash Institute of Pharmaceutical Sciences
Australia
Organizers
Organizers
Cutting edge assay technologies for studying molecular
and cellular pharmacology (joint symposium between BPS
and ASCPT)
Organizers
81
New insight into aquaporin function as drug targets
Organizer
Masato Yasui
Keio University School of Medicine
Japan
82
GPCR and RhoA Signaling in Physiology and Disease
Organizer
Joan Heller Brown
Department of Pharmacology, University of
California
USA
83
Biased agonism at G protein-coupled receptors: The
promise and the challenges
Organizer
Anthony P. Davenport
Experimental Medicine and
UK
Immunotherapeutics, University of Cambridge
84
African Indigenous Biodiversity: Gateway for Discovery
Organizer
Douglas Oliver
Pharmacology for Africa
80
5
South Africa